Megaplex (Megestrol Acetate)

Megestrol acetate is a synthetic progestin that binds progesterone receptors, producing anti‑estrogenic effects and glucocorticoid‑like activity. This dual action helps increase appetite and interferes with hormone‑driven tumor growth.

The specific dose of Megaplex is determined by the prescribing clinician based on the patient’s condition, weight, and response. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for megestrol acetate in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy and breastfeeding unless the potential benefit outweighs the risk, and only under medical supervision.

To order Megaplex, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Megaplex (megestrol acetate) is often compared with other appetite stimulants such as dronabinol or with other progestins like medroxyprogesterone acetate. Megaplex offers both appetite‑stimulating and anti‑estrogenic effects, whereas dronabinol primarily targets appetite without hormonal activity. Choice depends on the clinical scenario and patient tolerance.

Megaplex should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Megaplex is taken orally, usually with food or a light snack to reduce gastrointestinal discomfort. The tablet should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, adrenal suppression or Cushing‑like syndrome, severe allergic reactions, hepatic dysfunction, and significant hyperglycemia. Patients should seek immediate medical attention if they experience unexplained swelling, shortness of breath, severe abdominal pain, or signs of infection.

Megaplex is contraindicated in patients with known hypersensitivity to megestrol acetate, active thromboembolic disease, uncontrolled hypertension, severe liver impairment, or those who are pregnant without a clear medical justification. Caution is also advised for individuals with diabetes, adrenal insufficiency, or a history of cardiovascular disease.